Steph Alexander works in healthcare and pharmaceutical media strategy at Butler/Till, with a focus on direct-to-consumer marketing and point-of-care experiences. Their posts discuss patient experience, personalization, behavioral data, and how healthcare advertising can respond to changing conditions.
Most useful for pressure-testing healthcare media plans on point-of-care, personalization, measurement, and regulatory uncertainty.
Best for
Healthcare media agencies planning point-of-care and DTC pharma work under policy and budget pressure.
Not for
Vendor campaigns seeking product endorsement, or paid placement without proven audience data.
Key takeaways
Point of care is a care environment, not an advertising slot.
Behavioral data is not personalization; personalization is a trust exercise.
Under regulatory pressure, answer with evidence and act with intention rather than pausing.
Check first: Confirm current audience and engagement data, commercial terms, and inquiry route.
Main ideas
Point of care is a care environment, not an advertising slot · Under regulatory pressure, answer with evidence and act with intention rather than pausing · Ask better questions rather than perform certainty
Steph Alexander works in healthcare and pharmaceutical media strategy at Butler/Till and writes about direct-to-consumer advertising, point-of-care media, and patient experience.
In two DTC National conference reflections, they argue that point of care should be treated as part of the patient journey, not just a single advertising touchpoint, and that healthcare marketers should question exposure-based measurement and design experiences for both patients and providers.
They also track regulatory uncertainty and industry responses.
Ask for examples of signature books, shows, businesses, or earlier work to assess broader name-search interest.
Alexander turns conference observations into practical challenges to familiar healthcare-marketing assumptions.
One post distinguishes behavioral data from personalization: more behavioral signals do not automatically create a personalized experience, which they frame as a matter of trust, not just technology.
Another broadens the planning lens from a media placement to the clinical environment, while a regulatory reflection presents uncertainty as something to understand and act on, not smooth over with easy reassurance.
A short pre-conference post signals their Butler/Till affiliation and DTC National participation but offers little analysis.
Follow the conference reflections for a grounded perspective on healthcare media strategy.
Before treating these posts as a complete account of their public profile, ask for examples of signature work and earlier career context.
Steph Alexander writes about healthcare and pharmaceutical media strategy from the conference floor: point of care, patient experience, personalization, behavioral data, and how direct-to-consumer advertising should respond to political and regulatory pressure.
Read more
Three arguments run through the posts: the industry's limits in measuring and modeling patients are self-imposed and therefore fixable; personalization is a trust exercise rather than a technology purchase; and the right response to uncertainty is to keep asking better questions together instead of projecting certainty.
Point of care is a care environment, not an advertising slot
Alexander argues that point of care is an environment within the patient journey, not a moment in time or one touchpoint among many.
Read more
Treating it as a siloed channel understates its role.
The larger claim is that healthcare marketing's limits are self-created: the way the industry measures, models and markets patients can be corrected.
Two distinctions carry the argument: behavioral data is replacing exposure counts as the measure that matters, but it is not the same as personalization; and personalization is a trust exercise, not a technology feature.
Experience design must serve providers as well as patients, and the industry's models are overdue for a rethink — "maybe what we measure isn't what matters most."
The post opens with a line Alexander calls their "Media Brain" translation of the day: "Patients don't fit in a box—why should our strategies?"
It came out of a conversation about point of care as both a media channel and a clinical environment.
Alexander uses it to argue that what the industry measures is a choice, not a given.
Under regulatory pressure, answer with evidence and act with intention rather than pausing
Writing about the opening session of DTC National, Alexander describes arriving uneasy amid talk of outright advertising bans, shifting budgets and regulatory unknowns.
Read more
They did not know how it would be handled.
The answer is not reassurance but a working posture: understand the constraint properly, then act deliberately.
Alexander credits the framing to the speakers: James Potter explained tariffs, marketing deductibility and a proposed ad ban rather than simplifying them, and made the case for acting with intention based on commercial-speech protections and outcome data; Matt McNally argued for cultural movements instead of campaigns with fixed end dates; and Lucy Rose spoke about the OPDP mission and the value of evidence and high-quality submissions.
Alexander's conclusion is the closing line: the industry is "not hopeless, because we're not helpless, because we're not alone."
A shorter post from the same event focuses on networking — a big year for DTC, representing Butler/Till and an invitation to connect — without the critical framing of the two writeups.
Alexander sums up the day's charge: "stand strong, stand together, and stay the course. We've been here before, after all" — and says the industry is not hopeless, helpless or alone.
Ask better questions rather than perform certainty
Both substantive posts end by opening a conversation rather than closing an argument.
Read more
Alexander thanks the people who keep asking better questions "especially when the answers are still messy," and in the earlier post invites readers to work through what is next for DTC together, saying that having only questions right now is fine.
The hashtag "CuriousNotCertain" appears on the point-of-care writeup, and the two posts share the same move: state what was heard, flag what is unresolved, and hand the discussion back to the room.
This is a method as much as a mood — the ideas are presented as things to test with other practitioners, not as settled positions.
Mid-conference, Shane M. at Eversana handed Alexander a microphone, and they improvised a co-hosted roundtable.
Alexander names Travis Nevels, Jonathan Gayla and Helen Steriti as the people who spoke up and "helped us break the silence and raise the bar."
Start here for the clearest statement of Steph Alexander's argument about healthcare media: the ideas are specific, tied to a real event, and framed around how the industry measures and models patients rather than as a summary of the agenda.
Read more
A first-person day-one writeup from the DTC National conference.
Steph Alexander draws five takeaways from the sessions and hallway conversations: point of care works as an environment in the patient journey rather than a single moment, so treating it as one channel among many understates it; behavioral data is displacing exposure counts but is not the same thing as personalization; personalization is a trust exercise rather than a software feature; experience design has to serve providers as well as patients; and the measurement models the industry relies on are overdue for a rethink — "maybe what we measure isn't what matters most."
They also describe being handed a microphone mid-session and improvising a co-hosted roundtable with Shane M. at Eversana, naming three people who spoke up from the room.
For brands planning a campaign
Useful before a point-of-care or DTC planning conversation: it signals someone who will push back on exposure-based measurement and treating personalization as a bought feature. A brief that separates behavioral signals from personalization and defines point of care as a setting will get further than one that does not.
This is where the regulatory and political context comes through.
Read more
It shows how Steph Alexander frames risk in DTC advertising and what they consider a useful industry response.
A writeup of the conference's opening session.
Steph Alexander describes walking in uneasy amid talk of outright ad bans, shifting budgets, and regulatory unknowns, then credits James Potter with addressing tariffs, marketing deductibility, and an ad-ban proposal head on rather than simplifying them, and making the case for acting with intention.
The post also notes Matt McNally's keynote on trading short-lived campaigns for longer cultural movements and Lucy Rose's remarks on the OPDP mission.
Its closing line — "we're not hopeless, because we're not helpless, because we're not alone" — sums up how to work under political and regulatory uncertainty.
For brands planning a campaign
Relevant when a brief involves a category facing policy or reputational pressure. This piece favors working through the constraint with evidence and commercial-speech grounding over pausing activity—a useful posture to test in a DTC or public-affairs-adjacent campaign plan.
Open this to find out who Steph Alexander works for and where they show up in person.
Read more
Read it after the two conference writeups.
In a short pre-conference post, Steph Alexander calls it a big year for DTC in pharma, says they will represent Butler/Till and talk with people in the business about where it is headed, and asks who else will be there, inviting them to connect. The post identifies their employer and the event they treat as the year's main gathering for this work.
For brands planning a campaign
Useful for outreach timing and confirming a live presence at DTC National. It offers a natural hook for a conversation.
Treat point of care as part of the care environment
Steph Alexander argues that point of care is more than an advertising touchpoint: it is part of the patient journey and should not be siloed.
Read more
The post distinguishes behavioral data from exposure counts and notes that behavioral data alone does not amount to personalization.
Connects conference observations to practical questions about measurement, personalization and patient experience.
For brands planning a campaign
For a point-of-care or healthcare media brief, assess how a plan fits the clinical environment and patient journey, not just its placement and exposure metrics. Ask what behavioral signals will inform the plan and how the experience will earn trust.
Alexander sees experience design as relevant to patients and providers, and calls for industry collaboration to help doctors help patients.
Read more
They link media strategy to the conditions in which care is delivered.
For brands planning a campaign
A healthcare campaign can support the patient experience while meeting provider needs. Include provider workflow and the clinical setting in planning discussions rather than judging the campaign only as consumer advertising.
At DTC National, Alexander describes uncertainty around proposed advertising restrictions, budgets and regulation.
Read more
They highlight speakers who put policy questions in context, emphasized evidence and high-quality submissions, and encouraged the industry to respond together. In a separate conference post, Alexander says they were looking forward to representing Butler/Till and discussing the future of DTC.
Relays conference discussions and takeaways rather than offering a detailed regulatory analysis.
The short Butler/Till post signals interest in the topic.
For brands planning a campaign
For a DTC pharma brief, assess whether the strategy can respond thoughtfully to policy and budget changes and whether its claims and submissions are evidence-based. Ask for examples of relevant regulatory work and services.
Steph Alexander publicly represents Butler/Till, a marketing services firm, and posts about that role in the context of pharmaceutical DTC advertising.
Read more
The posts do not specify the form of the relationship; ask whether it is employment, an agency engagement, or something else.
Butler/Till
Disclosed partnership
Alexander says they are looking forward to representing Butler/Till at DTC National and speaking with pharma marketers about where the industry is heading.
Read more
The post establishes a public affiliation with the firm but does not specify the relationship; ask whether it is employment, an agency arrangement, or another type of engagement.
Steph Alexander's LinkedIn posts are a short series of write-ups from the DTC National conference, tracking how pharmaceutical and healthcare marketers discuss point of care, patient experience, personalization and direct-to-consumer advertising.
Read more
Start with the two longer conference posts, which walk through the sessions, arguments and open questions; the short pre-conference post offers a view of the same world from the networking side.
The tags below sort the posts by subject, specialty, format and intended reader, and offer a quick route into the themes they return to.
The three creators listed alongside are the closest available comparisons: all publish analytical healthcare commentary on LinkedIn, but each covers a different part of the sector — healthcare operations, health-tech commercialization and the clinical workforce.
Follow them for the sector view, not media and marketing strategy.
Both examine healthcare technology and commercial strategy as systems, rather than promote them.
Read more
Adil reads adoption and procurement data to argue what health technology suppliers and NHS organisations should do next; Alexander reads conference sessions the same way, using what was said in the room to argue what the industry should measure and how it should personalise.
Adil covers health-tech adoption, customer retention and commercial strategy inside the NHS; Alexander covers pharmaceutical media, point of care and consumer advertising.
Quintana posts long-form healthcare industry analysis on LinkedIn, moving from sector conditions to a recommended course of action for healthcare organisations — the same pattern Alexander uses to turn conference sessions into arguments about how the industry should measure, model and market to patients.
Read more
Quintana writes about healthcare operations leadership: payer strategy, provider networks, scaling programs and executive hiring. Alexander covers media, point of care and DTC advertising.
Both write short analytical posts diagnosing structural problems in US healthcare and arguing for changes in how organisations plan — Belkin on physician supply, staffing models and burnout; Alexander on measurement models and personalization.
Read more
Belkin covers the clinical workforce: recruitment, retention and coverage planning. Alexander covers marketing and media strategy.
For a healthcare media agency expanding into point-of-care and DTC pharma strategy, Steph Alexander has 1,029 LinkedIn followers as of October 10, 2026.
Read more
The three LinkedIn posts here align with that need, discussing DTC National, point-of-care as a media and clinical environment, behavioral data, personalization, patient experience, and healthcare media strategy.
To assess reach among pharma brand decision-makers, ask for recent LinkedIn analytics for comparable posts, including impressions, engagement, follower demographics, and any audience survey covering job function, seniority, and employer type.
If those data aren’t available, use a topic-led pilot before making a placement.
LinkedIn followers
1,029
LinkedIn profile metadata attached to the research · 2026-10-10
Need: a healthcare media agency is planning point-of-care and DTC pharma work for a brand whose category is under policy and budget pressure.
Read more
It wants a practitioner to pressure-test the plan’s measurement and personalization assumptions before the work goes to a client.
Steph Alexander fits this need.
Their posts make three arguments relevant to the job: point of care is an environment inside the patient journey, not a single touchpoint, so it should not be treated as one channel among many; behavioral data is displacing exposure counts but is not the same thing as personalization; and personalization is a trust exercise rather than a software feature.
They also frame experience design as a patient-and-provider problem and say the industry’s measurement models are overdue for a rethink.
On policy, their DTC National opening-session post works through ad-ban talk, tariff and deductibility questions, and regulatory uncertainty, arguing for action grounded in intention, law, and evidence rather than pausing activity.
An agency campaign plan that separates behavioral signals from personalization, treats point of care as a setting, and asks what to measure—not just what was exposed—will get further with them.
The only measured audience figure is 1,029 LinkedIn followers observed October 10, 2026, with no engagement or demographic data.
Treat them as a strategic voice and working-session participant, not a proven distribution channel; ask for current audience and engagement data before making a reach commitment.
Their posts do not list sponsorship terms or an inquiry route, so establish commercial terms directly.
When to choose a specialist
Need: a healthcare marketing technology vendor wants a sponsored thought-leadership series in which the creator endorses its personalization or measurement product as the answer for pharma and point-of-care marketers.
Read more
This is a poor fit.
Steph Alexander’s posts argue against the likely pitch: personalization is a trust exercise rather than a tech feature, and behavioral data is explicitly distinguished from personalization.
A product-endorsement campaign would conflict with the position they take in public.
Reach is also unproven for a paid campaign: one platform, 1,029 LinkedIn followers observed October 10, 2026, and no engagement, seniority, or employer-type data.
Their posts list no sponsorship format, deliverable, rate, or inquiry route.
Ask directly about commercial terms and audience data before considering a paid placement.
A campaign built around ranking personalization as a purchasable feature and measuring success by sponsored impressions would fail on both the editorial and information fronts.
A worked campaign example
Angle: “What we measure in point of care.”
Treat it as a co-hosted practitioner session and a short written series, not a product placement.
Shape: (1) a recorded 30–40 minute conversation or a three-part written series mirroring the roundtable format Steph Alexander described from DTC National, with one moderator, two to three brand or agency practitioners, and one point-of-care measurement lead; (2) each segment carries one argument from their posts—point of care as a clinical environment rather than a touchpoint, behavioral data versus exposure counts, personalization as a trust practice, and experience design that serves providers as well as patients; (3) close with a working one-page checklist the agency’s planners can use to separate behavioral signals from personalization in a live campaign plan.
Distribution would sit on the agency’s channels plus the creator’s LinkedIn account, with the client team using the checklist in planning meetings.
This shape stays within the arguments they already make, gives the buyer an inspectable artifact rather than a testimonial, and does not ask them to endorse a vendor.
Proceed only after confirming commercial terms directly; their posts list no sponsorship rate or inquiry route.
Confirm current engagement and audience data before making any reach commitment; the only measured number is 1,029 LinkedIn followers observed October 10, 2026.
Choose Suleman Adil when the decision moves beyond campaign planning to embedding the tool or supplier.
Read more
Their posts examine the NHS ambient voice market and argue that a supplier’s count of trust implementations shows access, not adoption: it does not reveal whether clinicians keep using the product, documentation time falls, it integrates with the record, or the contract renews.
They set out what buyers should weigh instead: clinical adoption, interoperability, information governance, measurable benefit from the start, ability to scale past a pilot, and the cost of adding another disconnected system.
They also argue that health-tech suppliers can grow revenue while eroding the customer trust that sustains it.
Adil is the stronger voice when a health system, payer, or provider client is choosing which technology to embed and how to evidence value at six, twelve, and twenty-four months.
Adil’s reasoning is grounded in UK NHS procurement and the vendor side of health-tech commercial strategy.
Their posts address procurement, not the campaign side of measurement: they contain no US DTC or prescription advertising, media channel planning, creative, or consumer personalization evidence.
For a campaign decision, ask for evidence of campaign planning and measurement.
Choose Michael Belkin instead when the need is provider-facing — a campaign or working session that depends on reaching health-system workforce and clinical leadership about physician supply, coverage, or clinician experience.
Read more
The posts argue that organizations can no longer treat physician staffing as reactive, that patient access and revenue stability track how well supply is anticipated, and that burnout is a leading indicator of turnover in the specialties with the least slack — emergency medicine, OBGYN, oncology, anesthesia, radiology — so locums, PRN, rapid-response, and fractional models need to be structural rather than last-resort. That is a better fit when the deliverable targets the people who own workforce planning, or when the judgement to be made is whether a provider-experience message would land with operations leadership.
The posts focus on workforce and staffing strategy, with claims based on Belkin’s own client experience (22 years; 80% of clients) rather than public data. For a media campaign, ask for evidence on media, channels, personalization, or audience measurement.
Choose Jessica Quintana instead when the need shifts from campaign to operating model.
Read more
The posts describe the gap between executives who look senior and those who have owned a profit-and-loss line, negotiated payer contracts, worked on MLR optimization, scaled national provider networks or multi-state operations, and carried EBITDA accountability, and they set out what boards and investor-backed healthcare organizations screen for, including value-based care execution across commercial, Medicare, and Medicaid. That is a better choice when the client is a payer, provider network, or investor-backed operator and the question is who should run operations or how to structure leadership rather than how to measure a point-of-care campaign.
The posts focus on operations and executive search, with no campaign, media, channel, or measurement material. For a DTC or point-of-care decision, ask for campaign-specific evidence.
This profile is built from three LinkedIn posts by Steph Alexander, read in full: two substantial write-ups from the DTC National conference covering point of care, behavioral data, personalization, patient and provider experience and regulatory pressure on DTC advertising, and one short pre-conference note in which Alexander says they will represent Butler/Till at the event.
The three posts have no publication dates, so the order of the material and any change in Alexander's thinking over time could not be assessed, and the posts cannot be placed on a timeline.
Steph Alexander's posts here are entirely conference commentary on LinkedIn.
They include no other channels, transcripts, video, interviews, media kit, or earlier career material, and the arrangement behind the Butler/Till affiliation is not described in the posts.
That leaves the broader name-search picture incomplete: signature books, shows, businesses, or earlier roles that might explain wider interest in this name are not established by the posts.
Anyone relying on this page should treat it as an account of what the posts show, not as a complete public profile.
Posts are quoted and paraphrased directly rather than summarized from headlines or snippets.
Similar-creator comparisons elsewhere on this page rest on two LinkedIn posts each from Suleman Adil, Jessica Quintana and Michael Belkin.
